Anti-Xa Directed Thromboprophylaxis in Critically Ill Patients with Coronavirus Disease 2019
Sign Up to like & getrecommendations! Published in 2022 at "Clinical and Applied Thrombosis/Hemostasis"
DOI: 10.1177/10760296221116350
Abstract: Objective: To compare Anti-Xa directed thromboprophylaxis using low molecular weight heparin (LMWH) (anti-Xa peak goal 0.2-0.5 IU/mL) to alternative anticoagulation strategies in critically ill COVID-19 patients. Methods: This was a retrospective, multicenter, single health-system study. Primary… read more here.
Keywords: ill patients; critically ill; directed thromboprophylaxis; thromboprophylaxis critically ... See more keywords
COVID-19: opening a new paradigm in thromboprophylaxis for critically ill patients?
Sign Up to like & getrecommendations! Published in 2020 at "Critical Care"
DOI: 10.1186/s13054-020-03052-9
Abstract: To the Editor: The novel infection caused by coronavirus SARS-CoV-2 determining COVID-19 disease causes alterations mainly in the respiratory system. Many reports have postulated a procoagulant state accompanying the respiratory distress with thrombosis at both… read more here.
Keywords: opening new; covid opening; new paradigm; thromboprophylaxis critically ... See more keywords